Company Filing History:
Years Active: 2008
Title: The Innovations of Henrik Sörensen
Introduction
Henrik Sörensen is a notable inventor based in Mölnlycke, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of thrombin inhibitors. His work is essential in addressing medical conditions that require anticoagulant treatments.
Latest Patents
Henrik Sörensen holds a patent for "Prodrugs of thrombin inhibitors." This patent includes compounds that are useful as prodrugs of inhibitors of trypsin-like proteases, such as thrombin. These compounds are particularly valuable in the treatment of conditions where inhibition of thrombin is required, such as thrombosis.
Career Highlights
Henrik Sörensen is associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca has allowed him to work on innovative solutions that address critical health issues. His expertise in the field has led to advancements in anticoagulant therapies.
Collaborations
Henrik has collaborated with notable colleagues, including Thomas Antonsson and David Gustafsson. These collaborations have fostered a productive environment for innovation and research within the pharmaceutical industry.
Conclusion
Henrik Sörensen's contributions to the field of thrombin inhibitors exemplify the impact of innovative thinking in medicine. His work continues to influence the development of effective treatments for thrombosis and related conditions.